Full RTA checklist coverage
Every cybersecurity item on the FDA acceptance checklist is present, labeled, and formatted exactly as reviewers expect in eSTAR.
FDA 2026 guidance aligned
Built to the February 2026 final premarket cybersecurity guidance and Section 524B(b)(1)–(3) - no second RTA on cyber grounds.
SBOM with VEX, ready to attach
Machine-readable SPDX or CycloneDX SBOM, NTIA minimum elements, plus VEX statements addressing every CVE in shipping software.
STRIDE threat model
End-to-end threat model with multi-patient harm, updateability, and use-environment views. Aligned to AAMI TIR57 / ANSI/AAMI SW96.
Pen test mapped to threat model
Device, cloud, mobile, and wireless attack surfaces tested independently. Findings traced back to threat model and risk file.
Fixed fee, unlimited retests
One quote covers rebuild, retest, and any follow-up exchanges until the cybersecurity section is accepted.